Hide Board Information

Show Board Information

Newcastle Resources Ltd. REPCF

Board Mod: Penny Stock Picks

Asst Mods:

Last Post: 07/16/2014 8:15:00 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 3

Newcastle Resources Ltd. (OTCMRKTS: REPCF) Stock Message Board

1. REPCF Company Profile

    

2. REPCF Time & Sales

    

3. REPCF Recent News

    

4. REPCF Filings

    

5. REPCF Financials

    

6. REPCF Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

5	REPCF Financials 07/16/2014 19:15:04 RepliCel	Emylers	07/16/2014 8:15:00 PM
4	Latest Replicel Life Sciences Inc (REPCF)	Stock_Tracker	03/11/2014 4:31:16 AM
3	REPCF 0.76 Stock Charts $REPCF 1 Month Chart	chartguy89	03/09/2014 12:57:51 PM
2	REPCF Stock Charts Last: +0.024 Saturday, March	chartguy89	03/01/2014 8:35:41 AM
1	Replicel Life Sciences is a company that has	Penny Stock Picks	04/28/2012 8:15:39 PM

Recent Articles

• Innovative Universities Shine in Kaltura Digital Engagement Awards
• QuinStreet's Strategic Move: Restarting Stock Buybacks
• Decent Holding Inc. Reports Strong H1 Results With 147% Revenue Growth
• Strategic Partnership: GameSquare Enhances Digital Assets With Animecoin
• Lifeward Appoints Almog Adar as Chief Financial Officer
• BeyondSpring's Q2 2025 Financial Review and Strategic Progress
• Red Cat's Teal Drones Earns Prestigious AS9100 Aerospace Certification
• LiveOne's Fiscal Growth: Revenue Insights and Future Outlook
• Mainz Biomed Achieves Swiss Approval for Innovative ColoAlert Test
• Kalaris Therapeutics Unveils Key Financial Insights and Updates
• Worksport's Impressive Q2 2025 Financial Performance and Outlook
• LiqTech International Reports Positive Q2 2025 Financial Growth
• Milestone Achieved: Arbli™ Shipment and Wholesaler Order Success
• Indaptus Therapeutics Shows Significant Progress and Growth
• Moleculin Biotech, Inc. Sees Significant Progress in Cancer Trials
• Ovid Therapeutics Shows Promising Advances in Drug Development
• Magna5 Achieves Recognition on the 2025 Inc. 5000 List
• Artelo Biosciences Highlights Promising Developments Amid Q2 Results
• GameSquare Expands Its Digital Footprint Through Animecoin Partnership
• Samsonite Group Reports Q2 2025 Financial Results Update
• Collaborative Initiative Funds $2.5 Million for Neurological Research
• VerifyMe's Financial Progress: Insights from Q2 2025 Results
• Pet King Brands Prepares for an Exciting Showcase at SUPERZOO
• Lucid Diagnostics Highlights Growth and Financial Performance
• Paradox Celebrates 5th Year on Inc. 5000 List for Growth
• Decent Holding Inc. Shines with Strong Financial Growth Report
• Unlocking Employee Potential: Enhancing Benefits Strategy
• Transforming Workplace Support for Parents: New Survey Insights
• Exploring Affordable Mansion Markets: A Housing Dreamland
• Revolutionizing Health Care: Humana and DrFirst's Innovative Collaboration
• Kythera Labs Soars on Inc. 5000 List, Paving Growth Ahead
• Constructor Secures Multiple Golds at 2025 Stevie Awards
• TetraScience's Innovative Solution for Streamlined Data Management
• The Keg Royalties Fund Completes Significant Acquisition Process
• Nasus Pharma Secures $10 Million in IPO for New Ventures
• Keg Royalties Fund Successfully Closes Transaction with Fairfax
• BSR REIT Expands Portfolio with $87.5 Million Acquisition
• Base Carbon's Latest Financial Achievements and Future Prospects
• Omni-Lite Industries Reports Impressive Growth in Q2 Results
• ProMIS Neurosciences 2025 Financial Growth and Developments
• Sanara MedTech's Impressive 2025 Q2 Results Hint Growth Ahead
• FOXO Technologies Transitioning to OTC Market Trading Soon
• Avèro Advisors Celebrates Continued Success and Growth Journey
• Majesco Honored as AI Maturity Leader for Insurance Solutions
• Exploring Growth Trends in the Personal Protective Equipment Market
• The Future of Military Laser Weapons: Market Insights and Growth
• Exploring the Future of AI in Synthetic Biology Market Growth
• Altus Group Addresses Transaction Speculations and Strategy
• China Faces Contraction in Loan Growth Amid Economic Woes
• Gauzy Ltd. Reports Strong Q2 Growth & New Product Launches